LifeStance (LFST) Files Rule 144 Notice for 4,804 Pre-IPO Shares

Rhea-AI Filing Summary

LifeStance Health Group, Inc. (LFST) filed a Form 144 reporting a proposed sale of 4,804 shares of common stock through Morgan Stanley & Co. LLC on approximately 08/18/2025. The filing lists an aggregate market value of $25,989.64 and indicates 388,936,394 shares outstanding. The shares were originally acquired on 06/10/2021 in a pre-IPO transaction from LifeStance Health Group Inc., with 27,568 shares noted as acquired at that time. No securities were reported sold in the past three months. The filer certifies they are not aware of undisclosed material adverse information about the issuer and the notice is marked LIVE.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice for a small block of pre-IPO shares; appears compliant and non-material to LFST holders.

The Form 144 shows a proposed brokered sale of 4,804 common shares with modest aggregate value relative to the company's outstanding shares. The acquisition date and pre-IPO nature are disclosed, and no recent sales are reported. From a compliance perspective, required fields (acquisition date, nature of acquisition, broker, approximate sale date, and representation about material non-public information) are provided. There is no indication in the filing of material impact on capitalization or control.

Equity Capital Markets Specialist

TL;DR: Transaction size is immaterial to market cap; should have limited market impact if executed as indicated.

The reported 4,804-share sale with an aggregate value of $25,989.64 is negligible versus the reported 388,936,394 shares outstanding. The seller acquired 27,568 shares pre-IPO, which suggests this sale is part of an insider or early-holder disposition under Rule 144. Given the small size, execution through a major broker and the lack of recent sales activity, market liquidity or price should not be materially affected by this specific disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley & Co. LLC 1585 Broadway New York NY 10036	4804	25989.64	388936394	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/10/2021	Pre-IPO Transactions	LifeStance Health Group Inc.			27568	06/10/2021	Equity interests in the Issuer were purchased pre-IPO.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does LifeStance Health Group's (LFST) Form 144 report?

The Form 144 reports a proposed sale of 4,804 common shares via Morgan Stanley with an aggregate market value of $25,989.64 and an approximate sale date of 08/18/2025.

When were the shares being sold originally acquired?

The filing indicates the shares were acquired on 06/10/2021 in a pre-IPO transaction from LifeStance Health Group Inc.

How many shares of LFST are outstanding according to the filing?

The filing lists 388,936,394 shares outstanding.

Has the filer sold any LFST securities in the past three months?

The Form 144 states Nothing to Report for securities sold during the past three months.

Who is the broker handling the proposed sale?

The sale is to be handled by Morgan Stanley & Co. LLC, 1585 Broadway, New York, NY 10036.